

06 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/06/3233718/0/en/Pulmovant-Announces-Completion-of-Enrollment-in-the-Phase-2-PHocus-Study-of-Mosliciguat-in-Patients-with-Pulmonary-Hypertension-Associated-with-Interstitial-Lung-Disease-PH-ILD.html